LGI-Flag was created by Medial EarlySign and is available through the Navify Algorithm Suite from Roche. The tool requires only a patient’s existing complete blood count results, along with the their birth year and gender, to calculate a risk score and flag those in need of follow-up screening, according to a March 12 press release sent to Becker’s.
In a real-world study conducted in 2022 using LGI-Flag, of patients flagged by the tool, 70% had a significant finding, 8% had colorectal cancer, 22% had advanced adenomas and 29% had adenomas/polyps.
Capital Digestive — the first GI specialty practice recognized as a Roche Diagnostics Center of Excellence — will use LGI-Flag to screen eligible patients using EHR data and clinical health repositories. It will then contact patients identified as “at risk.”
Capital Digestive recently partnered with Gastrointestinal & Liver Specialists of Tidewater and Gastroenterology in Southeastern Virginia and has expanded its network to more than 160 physicians and advanced care practitioners.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.